| First Author | Sistare FD | Year | 2002 |
| Journal | Int J Toxicol | Volume | 21 |
| Issue | 1 | Pages | 65-79 |
| PubMed ID | 11936901 | Mgi Jnum | J:75747 |
| Mgi Id | MGI:2177722 | Doi | 10.1080/10915810252826028 |
| Citation | Sistare FD, et al. (2002) Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions. Int J Toxicol 21(1):65-79 |
| abstractText | Transgenic mouse strains with genetic alterations known to play a role in the multistage process of carcinogenesis are being used increasingly as models for evaluating the human carcinogenic potential of chemicals and pharmaceuticals. The Tg.AC transgenic mouse is one of the strains currently being used in such alternative short-term carcinogenicity testing protocols. This review is focused on recent data from studies designed to evaluate this model's ability to discriminate carcinogens from noncarcinogens. Details relating to protocol design that can significantly impact study outcome are described. Data relating to mechanisms of chemical tumor induction in the Tg.AC model are reviewed, and questions have been formulated to encourage research to further guide appropriate future applications of this model. |
